Gilead Sciences, Inc. (BIT:1GILD)
Italy flag Italy · Delayed Price · Currency is EUR
106.58
-0.04 (-0.04%)
At close: Dec 4, 2025

Gilead Sciences Revenue

Gilead Sciences had revenue of $7.77B USD in the quarter ending September 30, 2025, with 2.97% growth. This brings the company's revenue in the last twelve months to $29.09B, up 2.78% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.75B with 6.04% growth.

Revenue (ttm)
$29.09B
Revenue Growth
+2.78%
P/S Ratio
5.21
Revenue / Employee
$1.65M
Employees
17,600
Market Cap
129.28B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.75B1.64B6.04%
Dec 31, 202327.12B-165.00M-0.60%
Dec 31, 202227.28B-24.00M-0.09%
Dec 31, 202127.31B2.62B10.60%
Dec 31, 202024.69B2.24B9.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Recordati Industria Chimica e Farmaceutica 2.55B
DiaSorin 1.21B
Amplifon 2.41B
EL.En. 580.41M
Philogen 84.66M
Safilo Group 998.89M
Pharmanutra 127.15M
GPI S.p.A. 531.42M
Revenue Rankings